Thursday, November 20, 2008 - 8:21PM EST

Review Articles

41. The changing landscape of the medical management of skeletal metastases in nonsmall cell lung cancer.

Author
Kosteva J; Langer C;
Institution
Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
Journal
Curr Opin Oncol. 2008 Mar;20(2):155-61.
Abstract URL
Click here to view abstract

42. Remediastinoscopy.

Author
Van Schil P; De Waele M; Hendriks J; Lauwers P;
Institution
Department of Thoracic and Vascular Surgery, University Hospital of Antwerp, Antwerp, Belgium. paul.van.schil@uza.be
Journal
J Thorac Oncol. 2007 Apr;2(4):365-6.
Abstract URL
Click here to view abstract

43. Management of unresected stage III non-small cell lung cancer: a systematic review.

Author
Okawara G; Mackay JA; Evans WK; Ung YC;
Institution
Juravinski Cancer Centre at Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.
Journal
J Thorac Oncol. 2006 May;1(4):377-93.
Abstract URL
Click here to view abstract

44. Salvage therapy in patients with advanced non-small cell lung cancer.

Author
Bedano PM; Hanna NH;
Institution
Department of Medicine, Division of Oncology, Indiana University, Indianapolis, Indiana 46202, USA. pabedano@iupui.edu
Journal
J Thorac Oncol. 2006 Jul;1(6):582-7.
Abstract URL
Click here to view abstract

45. A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in non-small cell lung cancer.

Author
Burdett S; Stewart LA; Rydzewska L;
Institution
Meta-analysis Group, MRC Clinical Trials Unit, London, United Kingdom. sb@ctu.mrc.ac.uk
Journal
J Thorac Oncol. 2006 Sep;1(7):611-21.
Abstract URL
Click here to view abstract

46. Novel cytotoxic agents for non-small cell lung cancer.

Author
Edelman MJ;
Institution
University of Maryland Greenebaum Cancer Center, Baltimore, MD 21201, USA. medelman@umm.edu
Journal
J Thorac Oncol. 2006 Sep;1(7):752-5.
Abstract URL
Click here to view abstract

47. Immune-modulating vaccines in non-small cell lung cancer.

Author
Nemunaitis J; Murray N;
Institution
Mary Crowley Medical Research Center, Dallas, Texas, USA.
Journal
J Thorac Oncol. 2006 Sep;1(7):756-61.
Abstract URL
Click here to view abstract

48. Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: a systematic review and practice guideline.

Author
Noble J; Ellis PM; Mackay JA; Evans WK;
Institution
Hopital Regional de Sudbury Regional Hospital, Regional Cancer Program, Sudbury, ON, Canada.
Journal
J Thorac Oncol. 2006 Nov;1(9):1042-58.
Abstract URL
Click here to view abstract

49. Prognostic value of fluorodeoxyglucose positron emission tomography in non-small cell lung cancer: a review.

Author
Pillot G; Siegel BA; Govindan R;
Institution
Division of Medical Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Journal
J Thorac Oncol. 2006 Feb;1(2):152-9.
Abstract URL
Click here to view abstract

50. Adjuvant chemotherapy for resected non-small cell lung cancer.

Author
Booth CM; Shepherd FA;
Institution
Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
Journal
J Thorac Oncol. 2006 Feb;1(2):180-7.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7 8 9